e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Development of hepatopulmonary syndrome during combination therapy for portopulmonary hypertension
Karen M. Olsson, Katrin Meyer, Dominik Berliner, Marius M. Hoeper
Source:
Eur Respir J, 53 (1) 1801880; 10.1183/13993003.01880-2018
Journal Issue:
January
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Karen M. Olsson, Katrin Meyer, Dominik Berliner, Marius M. Hoeper. Development of hepatopulmonary syndrome during combination therapy for portopulmonary hypertension. Eur Respir J, 53 (1) 1801880; 10.1183/13993003.01880-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Hepatopulmonary syndrome following portopulmonary hypertension
Source: Eur Respir J 2007; 29: 1277-1280
Year: 2007
Liver transplantation in hepatopulmonary syndrome and portopulmonary hypertension
Source: Annual Congress 2003 - Pulmonary-hepatic disorders (PHD) - recommendations of the PHD ERS Task Force for management of hepatopulmonary syndrome and portopulmonary hypertension
Year: 2003
Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview
Source: Eur Respir Rev 2012 21:223-233
Year: 2012
Association between portopulmonary hypertension and hepatopulmonary syndrome in cirrhotics, candidates to hepatic transplantation
Source: Annual Congress 2003 - Pulmonary hypertension
Year: 2003
The lung in liver disease: hepatopulmonary syndrome and portopulmonary hypertension
Source: Eur Respir Monogr 2019; 86: 262-277
Year: 2019
Iloprost treatment in portopulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
How should we treat portopulmonary hypertension?
Source: Eur Respir J 2006; 28: 466-467
Year: 2006
Sildenafil treatment for portopulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 651s
Year: 2006
Ambrisentan for therapy of portopulmonary hypertension (POPH): Update on safety and efficacy
Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments
Year: 2012
An autopsy case of portopulmonary hypertension associated with idiopathic portal hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
Hepatopulmonary syndrome among patients of cirrhosis of liver and portal hypertension
Source: Annual Congress 2007 - Pulmonary circulation
Year: 2007
The hepatopulmonary syndrome
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=112
Year: 2005
The metabolic syndrome and pulmonary hypertension
Source: Virtual Congress 2020 – Pulmonary vascular diseases
Year: 2020
Experience with inhaled iloprost and bosentan in portopulmonary hypertension
Source: Eur Respir J 2007; 30: 1096-1102
Year: 2007
Portopulmonary hypertension: a further clue to pathogenesis?
Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension
Year: 2005
Sildenafil for patients with portopulmonary hypertension, candidates to hepatic transplant
Source: Eur Respir J 2004; 24: Suppl. 48, 109s
Year: 2004
Acute effects of inhaled iloprost in portopulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 547s
Year: 2006
Sildenafil treatment for portopulmonary hypertension
Source: Eur Respir J 2006; 28: 563-567
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept